164 related articles for article (PubMed ID: 989384)
41. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
[TBL] [Abstract][Full Text] [Related]
42. Biochemical methods to assess the action of clozapine and haloperidol on presynaptic dopamine neurons.
Zivkovic B
Adv Biochem Psychopharmacol; 1977; 16():625-30. PubMed ID: 18905
[No Abstract] [Full Text] [Related]
43. Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
Rupniak NM; Briggs RS; Petersen MM; Mann S; Reavill C; Jenner P; Marsden CD
Clin Neuropharmacol; 1986; 9(3):282-92. PubMed ID: 3719573
[TBL] [Abstract][Full Text] [Related]
44. [Receptor-blockade and receptor-hypersensitivity following neuroleptic treatment (author's transl)].
Nielsen IM; Christensen AV; Hyttel J
Arzneimittelforschung; 1976; 26(6):1090-2. PubMed ID: 989383
[TBL] [Abstract][Full Text] [Related]
45. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
Rivest R; Marsden CA
Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513
[TBL] [Abstract][Full Text] [Related]
46. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
Allen RM; Flemenbaum A
Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
[No Abstract] [Full Text] [Related]
47. Clozapine and the dopamine hypothesis of schizophrenia, a critical appraisal.
Bürki HR; Eichenberger E; Sayers AC; White TG
Pharmakopsychiatr Neuropsychopharmakol; 1975 May; 8(3):115-21. PubMed ID: 1241920
[TBL] [Abstract][Full Text] [Related]
48. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
Lipska BK; Weinberger DR
Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
[TBL] [Abstract][Full Text] [Related]
49. Effects of fluperlapine on dopaminergic systems in rat brain.
Burki HR
Psychopharmacology (Berl); 1986; 89(1):77-84. PubMed ID: 2942961
[TBL] [Abstract][Full Text] [Related]
50. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
Lindgren S
J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
[TBL] [Abstract][Full Text] [Related]
51. Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine.
Cuomo V; Cagiano R; Mocchetti I; Coen E; Cattabeni F; Racagni G
Psychopharmacology (Berl); 1983; 81(3):239-43. PubMed ID: 6417713
[TBL] [Abstract][Full Text] [Related]
52. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Allen RM; Lane JD; Brauchi JT
Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
[TBL] [Abstract][Full Text] [Related]
53. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum.
Rothblat DS; Schneider JS
Neurosci Lett; 1997 Jun; 228(2):119-22. PubMed ID: 9209113
[TBL] [Abstract][Full Text] [Related]
54. Intrastriatal injection of DL-2-amino-5-phosphonovaleric acid (AP-5) induces sniffing stereotypy that is antagonized by haloperidol and clozapine.
Schmidt WJ
Psychopharmacology (Berl); 1986; 90(1):123-30. PubMed ID: 2876450
[TBL] [Abstract][Full Text] [Related]
55. Differential sensitivity to amphetamine following long-term treatment with clozapine or haloperidol.
Rebec GV; Peirson EE; McPherson FA; Brugge K
Psychopharmacology (Berl); 1982; 77(4):360-6. PubMed ID: 6813898
[TBL] [Abstract][Full Text] [Related]
56. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
Costall B; Naylor RJ
Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
[TBL] [Abstract][Full Text] [Related]
57. Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of alpha 1-noradrenergic receptors demonstrated by in vivo voltammetry.
Lane RF; Blaha CD; Rivet JM
Brain Res; 1988 Sep; 460(2):398-401. PubMed ID: 2852047
[TBL] [Abstract][Full Text] [Related]
58. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
Carvey PM; Kao LC; Zhang TJ; Amdur RL; Lin DH; Singh R; Klawans HL
Pharmacol Biochem Behav; 1990 Feb; 35(2):291-300. PubMed ID: 2320636
[TBL] [Abstract][Full Text] [Related]
59. Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.
Waldmeier PC; Maître L
Eur J Pharmacol; 1976 Jul; 38(1):197-203. PubMed ID: 954831
[TBL] [Abstract][Full Text] [Related]
60. Role of dopaminergic mechanisms in the central amygdalar nucleus in the regulation of stress-induced gastric ulcer formation in rats.
Ray A; Henke PG
Indian J Med Res; 1989 Jun; 90():224-8. PubMed ID: 2767748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
